Furuta H, Iwasaki N, Oda N, Hinokio Y, Horikawa Y, Yamagata K, Yano N, Sugahiro J, Ogata M, Ohgawara H, Omori Y, Iwamoto Y, Bell G I
Department of Biochemistry and Molecular Biology, University of Chicago, IL 60637, USA.
Diabetes. 1997 Oct;46(10):1652-7. doi: 10.2337/diacare.46.10.1652.
Hepatocyte nuclear factor-4 alpha (HNF-4 alpha) is a member of the nuclear receptor superfamily, a class of ligand-activated transcription factors. A nonsense mutation in the gene encoding this transcription factor was recently found in a white family with one form of maturity-onset diabetes of the young, MODY1. Here, we report the exon-intron organization and partial sequence of the human HNF-4 alpha gene. In addition, we have screened the 12 exons, flanking introns and minimal promoter region for mutations in a group of 57 unrelated Japanese subjects with early-onset NIDDM/MODY of unknown cause. Eight nucleotide substitutions were noted, of which one resulted in the mutation of a conserved arginine residue, Arg127 (CGG)-->Trp (TGG) (designated R127W), located in the T-box, a region of the protein that may play a role in HNF-4 alpha dimerization and DNA binding. This mutation was not found in 214 unrelated nondiabetic subjects (53 Japanese, 53 Chinese, 51 white, and 57 African-American). The R127W mutation was only present in three of five diabetic members in this family, indicating that it is not the only cause of diabetes in this family. The remaining seven nucleotide substitutions were located in the proximal promoter region and introns. They are not predicted to affect the transcription of the gene or mRNA processing and represent polymorphisms and rare variants. The results suggest that mutations in the HNF-4 alpha gene may cause early-onset NIDDM/MODY in Japanese but they are less common than mutations in the HNF-1 alpha/MODY3 gene. The information on the sequence of the HNF-4 alpha gene and its promoter region will facilitate the search for mutations in other populations and studies of the role of this gene in determining normal pancreatic beta-cell function.
肝细胞核因子-4α(HNF-4α)是核受体超家族的成员,属于一类配体激活的转录因子。最近在一个患有青年发病的成年型糖尿病(MODY1)的白人家庭中发现了编码这种转录因子的基因中的一个无义突变。在此,我们报告人类HNF-4α基因的外显子-内含子组织和部分序列。此外,我们在一组57名病因不明的早发型非胰岛素依赖型糖尿病/ MODY的无关日本受试者中,对12个外显子、侧翼内含子和最小启动子区域进行了突变筛查。发现了8个核苷酸替换,其中一个导致保守的精氨酸残基Arg127(CGG)突变为色氨酸(TGG)(命名为R127W),该残基位于T盒中,这是蛋白质中可能在HNF-4α二聚化和DNA结合中起作用的区域。在214名无关的非糖尿病受试者(53名日本人、53名中国人、51名白人、57名非裔美国人)中未发现这种突变。R127W突变仅存在于该家族的五名糖尿病成员中的三名中,表明它不是该家族糖尿病的唯一病因。其余七个核苷酸替换位于近端启动子区域和内含子中。预计它们不会影响基因转录或mRNA加工,代表多态性和罕见变异。结果表明,HNF-4α基因中的突变可能导致日本人早发型非胰岛素依赖型糖尿病/ MODY,但它们比HNF-1α/ MODY3基因中的突变少见。HNF-4α基因及其启动子区域的序列信息将有助于在其他人群中寻找突变,并有助于研究该基因在确定正常胰腺β细胞功能中的作用。